Regenxbio financial statements

리젠엑스바이오NASDAQ:RGNX · Nasdaq · Healthcare · sector #17
$7.45-3.99%
2026-10-06 close

Regenxbio's published financial data is dated 2026-10-04. 2024 revenue was $83M. 2024 operating profit was −$233M.

Reported results

Regenxbio notifications

Quantus Signal · live data · not investment advice · Privacy Policy